NCT05275179

Pharmacokinetic of Posaconazole in Critically Ill Patients

Pharmacokinetic of Intravenous Posaconazole in Critically Ill Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 10 (actual)
• Sponsor: Universitätsklinikum Hamburg-Eppendorf · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial.

Detailed description

The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial. Plasma specimens will be retrieved on consecutive days (max. 7 days) in order to measure posaconazole levels during the treatment episode.

Conditions

• Therapeutic Drug Monitoring
• Critical Illness

Interventions

Type	Name	Description
OTHER	Posaconazole Therapeutic Drug Monitoring	Therapeutic Drug Monitoring is performed by measuring posaconazole concentrations in serum on seven consecutive days (anticipated).

Timeline

• Start date: 2021-02-11
• Primary completion: 2022-03-30
• Completion: 2022-11-01
• First posted: 2022-03-11
• Last updated: 2022-11-08

Locations

1 site across 1 country: Germany